Abstract:Autoimmune diseases are characterized by aberrant immune responses against healthy cells and tissues. However, the exact mechanisms underlying the development of these conditions remain unknown. CD4+CD25+ regulatory T cells (Tregs) are a subset of mature T cells which have an important role in maintaining immune homeostasis and preventing autoimmune diseases. Forkhead box p3 (Foxp3), a member of the fork head transcription factor family, is recognized as a marker of CD4+CD25+ Tregs. The decreased number and/or function of CD4+CD25+ Tregs in peripheral blood and related tissues has been demonstrated in systemic lupus erythematosus, systemic sclerosis, and other autoimmune diseases, which are at least partially regulated by epigenetic mechanisms. Epigenetics refers to the study of potentially heritable alterations in gene expression without underlying changes of the nucleotide sequence, mainly including DNA methylation, histone modification, and microRNAs (miRNAs). For example, DNA methylation status of CpG islands on the Foxp3 gene, which may be affected by normal aging and regulated by environmental factors, plays an important role in modulating the homeostasis of Foxp3 expression in Tregs. Foxp3 gene in Tregs also shows distinct acetylation and trimethylation levels of histone H3 and H4 when compared with effector T cells, leading to an open chromatin structure. MicroRNAs such as miR-155, miR-126, and miR-10a also exert an important influence on the differentiation, development, and immunological functions of Tregs. Aberrant epigenetic modifications affecting Foxp3 and other key genes in Tregs contribute to disease activity and tissue inflammation in autoimmune diseases, which holds great potential for providing novel targets for epigenetic therapies. Advances in research into the epigenetic regulation of CD4+CD25+ Tregs may also lead to the identification of new epigenetic biomarkers for diagnosis and prognosis.

Foxp3, Regulatory T Cell, and Autoimmune Diseases

Foxp3+ Regulatory T Cells: a Protagonist in the “movie’’ of Autoimmune Diseases?

Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases.

Research Progress on Regulatory T Cells and Their Relationship with Autoimmune Diseases

The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases

Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications

Different Subpopulations of Regulatory T Cells in Human Autoimmune Disease, Transplantation, and Tumor Immunity

Regulatory T Cells: the Many Faces of Foxp3

The regulation of immune tolerance by FOXP3

Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations

The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases

FoxP3 in T<sub>reg</sub> cell biology: a molecular and structural perspective

The Progress and Prospect of Regulatory T Cells in Autoimmune Diseases

Therapeutic Potential of TGF-β-induced CD4+ Foxp3+ Regulatory T Cells in Autoimmune Diseases

Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases

FoxP3 in T reg cell biology: a molecular and structural perspective

Function and Role of Regulatory T Cells in Rheumatoid Arthritis

Epigenetic Enzymes Are the Therapeutic Targets for CD4(+)CD25(+/high)Foxp3(+) Regulatory T Cells.

Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?

FoxP3 in Treg Cell Biology: a Molecular and Structural Perspective

Control of Regulatory T Cells and T Helper Cells in Human Diseases: from Bench to Bedside.